Global Pre-Implantation Genetic Diagnosis (PGD) Market Research Report 2026(Status and Outlook)
Pre-Implantation Genetic Diagnosis (PGD) is the genetic profiling of embryos prior to implantation (as a form of embryo profiling), and sometimes even of oocytes prior to fertilization.The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
The global Pre-Implantation Genetic Diagnosis (PGD) market size was estimated at USD 111.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 4.30% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Pre-Implantation Genetic Diagnosis (PGD) market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Pre-Implantation Genetic Diagnosis (PGD) market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Pre-Implantation Genetic Diagnosis (PGD) market.
Global Pre-Implantation Genetic Diagnosis (PGD) Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Roche
Genea Limited
Quest Diagnostics
Illumina, Inc.
Natera, Inc.
Cooper Medical, Inc.
LabCorp
California Pacific Medical Center (CPMC)
Thermo Fisher Scientific Inc.
IGENOMIX
Reproductive Genetic Innovations
CombiMatrix
Market Segmentation (by Type)
Chromosomal Abnormalities
X-linked Diseases
Freeze Embryo Testing
Aneuploidy Screening
HLA
Others
Market Segmentation (by Application)
Stem Cell Therapy
IVF Prognosis
Late-Onset Genetic Disorders
Inherited Genetic Disease
Others
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Pre-Implantation Genetic Diagnosis (PGD) Market
Overview of the regional outlook of the Pre-Implantation Genetic Diagnosis (PGD) Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Pre-Implantation Genetic Diagnosis (PGD) Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Pre-Implantation Genetic Diagnosis (PGD), their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
The global Pre-Implantation Genetic Diagnosis (PGD) market size was estimated at USD 111.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 4.30% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Pre-Implantation Genetic Diagnosis (PGD) market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Pre-Implantation Genetic Diagnosis (PGD) market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Pre-Implantation Genetic Diagnosis (PGD) market.
Global Pre-Implantation Genetic Diagnosis (PGD) Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Roche
Genea Limited
Quest Diagnostics
Illumina, Inc.
Natera, Inc.
Cooper Medical, Inc.
LabCorp
California Pacific Medical Center (CPMC)
Thermo Fisher Scientific Inc.
IGENOMIX
Reproductive Genetic Innovations
CombiMatrix
Market Segmentation (by Type)
Chromosomal Abnormalities
X-linked Diseases
Freeze Embryo Testing
Aneuploidy Screening
HLA
Others
Market Segmentation (by Application)
Stem Cell Therapy
IVF Prognosis
Late-Onset Genetic Disorders
Inherited Genetic Disease
Others
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Pre-Implantation Genetic Diagnosis (PGD) Market
Overview of the regional outlook of the Pre-Implantation Genetic Diagnosis (PGD) Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Pre-Implantation Genetic Diagnosis (PGD) Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Pre-Implantation Genetic Diagnosis (PGD), their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Pre-Implantation Genetic Diagnosis (PGD)
1.2 Key Market Segments
1.2.1 Pre-Implantation Genetic Diagnosis (PGD) Segment by Type
1.2.2 Pre-Implantation Genetic Diagnosis (PGD) Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 PRE-IMPLANTATION GENETIC DIAGNOSIS (PGD) MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Pre-Implantation Genetic Diagnosis (PGD) Market Size (M USD) Estimates and Forecasts (2020-2035)
2.1.2 Global Pre-Implantation Genetic Diagnosis (PGD) Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 PRE-IMPLANTATION GENETIC DIAGNOSIS (PGD) MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Pre-Implantation Genetic Diagnosis (PGD) Product Life Cycle
3.3 Global Pre-Implantation Genetic Diagnosis (PGD) Sales by Manufacturers (2020-2025)
3.4 Global Pre-Implantation Genetic Diagnosis (PGD) Revenue Market Share by Manufacturers (2020-2025)
3.5 Pre-Implantation Genetic Diagnosis (PGD) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Pre-Implantation Genetic Diagnosis (PGD) Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Pre-Implantation Genetic Diagnosis (PGD) Market Competitive Situation and Trends
3.8.1 Pre-Implantation Genetic Diagnosis (PGD) Market Concentration Rate
3.8.2 Global 5 and 10 Largest Pre-Implantation Genetic Diagnosis (PGD) Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 PRE-IMPLANTATION GENETIC DIAGNOSIS (PGD) INDUSTRY CHAIN ANALYSIS
4.1 Pre-Implantation Genetic Diagnosis (PGD) Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF PRE-IMPLANTATION GENETIC DIAGNOSIS (PGD) MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Pre-Implantation Genetic Diagnosis (PGD) Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Pre-Implantation Genetic Diagnosis (PGD) Market
5.7 ESG Ratings of Leading Companies
6 PRE-IMPLANTATION GENETIC DIAGNOSIS (PGD) MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Pre-Implantation Genetic Diagnosis (PGD) Sales Market Share by Type (2020-2025)
6.3 Global Pre-Implantation Genetic Diagnosis (PGD) Market Size by Type (2020-2025)
6.4 Global Pre-Implantation Genetic Diagnosis (PGD) Price by Type (2020-2025)
7 PRE-IMPLANTATION GENETIC DIAGNOSIS (PGD) MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Pre-Implantation Genetic Diagnosis (PGD) Market Sales by Application (2020-2025)
7.3 Global Pre-Implantation Genetic Diagnosis (PGD) Market Size (M USD) by Application (2020-2025)
7.4 Global Pre-Implantation Genetic Diagnosis (PGD) Sales Growth Rate by Application (2020-2025)
8 PRE-IMPLANTATION GENETIC DIAGNOSIS (PGD) MARKET SALES BY REGION
8.1 Global Pre-Implantation Genetic Diagnosis (PGD) Sales by Region
8.1.1 Global Pre-Implantation Genetic Diagnosis (PGD) Sales by Region
8.1.2 Global Pre-Implantation Genetic Diagnosis (PGD) Sales Market Share by Region
8.2 Global Pre-Implantation Genetic Diagnosis (PGD) Market Size by Region
8.2.1 Global Pre-Implantation Genetic Diagnosis (PGD) Market Size by Region
8.2.2 Global Pre-Implantation Genetic Diagnosis (PGD) Market Size by Region
8.3 North America
8.3.1 North America Pre-Implantation Genetic Diagnosis (PGD) Sales by Country
8.3.2 North America Pre-Implantation Genetic Diagnosis (PGD) Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Pre-Implantation Genetic Diagnosis (PGD) Sales by Country
8.4.2 Europe Pre-Implantation Genetic Diagnosis (PGD) Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Pre-Implantation Genetic Diagnosis (PGD) Sales by Region
8.5.2 Asia Pacific Pre-Implantation Genetic Diagnosis (PGD) Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Pre-Implantation Genetic Diagnosis (PGD) Sales by Country
8.6.2 South America Pre-Implantation Genetic Diagnosis (PGD) Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Pre-Implantation Genetic Diagnosis (PGD) Sales by Region
8.7.2 Middle East and Africa Pre-Implantation Genetic Diagnosis (PGD) Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 PRE-IMPLANTATION GENETIC DIAGNOSIS (PGD) MARKET PRODUCTION BY REGION
9.1 Global Production of Pre-Implantation Genetic Diagnosis (PGD) by Region(2020-2025)
9.2 Global Pre-Implantation Genetic Diagnosis (PGD) Revenue Market Share by Region (2020-2025)
9.3 Global Pre-Implantation Genetic Diagnosis (PGD) Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Pre-Implantation Genetic Diagnosis (PGD) Production
9.4.1 North America Pre-Implantation Genetic Diagnosis (PGD) Production Growth Rate (2020-2025)
9.4.2 North America Pre-Implantation Genetic Diagnosis (PGD) Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Pre-Implantation Genetic Diagnosis (PGD) Production
9.5.1 Europe Pre-Implantation Genetic Diagnosis (PGD) Production Growth Rate (2020-2025)
9.5.2 Europe Pre-Implantation Genetic Diagnosis (PGD) Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Pre-Implantation Genetic Diagnosis (PGD) Production (2020-2025)
9.6.1 Japan Pre-Implantation Genetic Diagnosis (PGD) Production Growth Rate (2020-2025)
9.6.2 Japan Pre-Implantation Genetic Diagnosis (PGD) Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Pre-Implantation Genetic Diagnosis (PGD) Production (2020-2025)
9.7.1 China Pre-Implantation Genetic Diagnosis (PGD) Production Growth Rate (2020-2025)
9.7.2 China Pre-Implantation Genetic Diagnosis (PGD) Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Roche
10.1.1 Roche Basic Information
10.1.2 Roche Pre-Implantation Genetic Diagnosis (PGD) Product Overview
10.1.3 Roche Pre-Implantation Genetic Diagnosis (PGD) Product Market Performance
10.1.4 Roche Business Overview
10.1.5 Roche SWOT Analysis
10.1.6 Roche Recent Developments
10.2 Genea Limited
10.2.1 Genea Limited Basic Information
10.2.2 Genea Limited Pre-Implantation Genetic Diagnosis (PGD) Product Overview
10.2.3 Genea Limited Pre-Implantation Genetic Diagnosis (PGD) Product Market Performance
10.2.4 Genea Limited Business Overview
10.2.5 Genea Limited SWOT Analysis
10.2.6 Genea Limited Recent Developments
10.3 Quest Diagnostics
10.3.1 Quest Diagnostics Basic Information
10.3.2 Quest Diagnostics Pre-Implantation Genetic Diagnosis (PGD) Product Overview
10.3.3 Quest Diagnostics Pre-Implantation Genetic Diagnosis (PGD) Product Market Performance
10.3.4 Quest Diagnostics Business Overview
10.3.5 Quest Diagnostics SWOT Analysis
10.3.6 Quest Diagnostics Recent Developments
10.4 Illumina, Inc.
10.4.1 Illumina, Inc. Basic Information
10.4.2 Illumina, Inc. Pre-Implantation Genetic Diagnosis (PGD) Product Overview
10.4.3 Illumina, Inc. Pre-Implantation Genetic Diagnosis (PGD) Product Market Performance
10.4.4 Illumina, Inc. Business Overview
10.4.5 Illumina, Inc. Recent Developments
10.5 Natera, Inc.
10.5.1 Natera, Inc. Basic Information
10.5.2 Natera, Inc. Pre-Implantation Genetic Diagnosis (PGD) Product Overview
10.5.3 Natera, Inc. Pre-Implantation Genetic Diagnosis (PGD) Product Market Performance
10.5.4 Natera, Inc. Business Overview
10.5.5 Natera, Inc. Recent Developments
10.6 Cooper Medical, Inc.
10.6.1 Cooper Medical, Inc. Basic Information
10.6.2 Cooper Medical, Inc. Pre-Implantation Genetic Diagnosis (PGD) Product Overview
10.6.3 Cooper Medical, Inc. Pre-Implantation Genetic Diagnosis (PGD) Product Market Performance
10.6.4 Cooper Medical, Inc. Business Overview
10.6.5 Cooper Medical, Inc. Recent Developments
10.7 LabCorp
10.7.1 LabCorp Basic Information
10.7.2 LabCorp Pre-Implantation Genetic Diagnosis (PGD) Product Overview
10.7.3 LabCorp Pre-Implantation Genetic Diagnosis (PGD) Product Market Performance
10.7.4 LabCorp Business Overview
10.7.5 LabCorp Recent Developments
10.8 California Pacific Medical Center (CPMC)
10.8.1 California Pacific Medical Center (CPMC) Basic Information
10.8.2 California Pacific Medical Center (CPMC) Pre-Implantation Genetic Diagnosis (PGD) Product Overview
10.8.3 California Pacific Medical Center (CPMC) Pre-Implantation Genetic Diagnosis (PGD) Product Market Performance
10.8.4 California Pacific Medical Center (CPMC) Business Overview
10.8.5 California Pacific Medical Center (CPMC) Recent Developments
10.9 Thermo Fisher Scientific Inc.
10.9.1 Thermo Fisher Scientific Inc. Basic Information
10.9.2 Thermo Fisher Scientific Inc. Pre-Implantation Genetic Diagnosis (PGD) Product Overview
10.9.3 Thermo Fisher Scientific Inc. Pre-Implantation Genetic Diagnosis (PGD) Product Market Performance
10.9.4 Thermo Fisher Scientific Inc. Business Overview
10.9.5 Thermo Fisher Scientific Inc. Recent Developments
10.10 IGENOMIX
10.10.1 IGENOMIX Basic Information
10.10.2 IGENOMIX Pre-Implantation Genetic Diagnosis (PGD) Product Overview
10.10.3 IGENOMIX Pre-Implantation Genetic Diagnosis (PGD) Product Market Performance
10.10.4 IGENOMIX Business Overview
10.10.5 IGENOMIX Recent Developments
10.11 Reproductive Genetic Innovations
10.11.1 Reproductive Genetic Innovations Basic Information
10.11.2 Reproductive Genetic Innovations Pre-Implantation Genetic Diagnosis (PGD) Product Overview
10.11.3 Reproductive Genetic Innovations Pre-Implantation Genetic Diagnosis (PGD) Product Market Performance
10.11.4 Reproductive Genetic Innovations Business Overview
10.11.5 Reproductive Genetic Innovations Recent Developments
10.12 CombiMatrix
10.12.1 CombiMatrix Basic Information
10.12.2 CombiMatrix Pre-Implantation Genetic Diagnosis (PGD) Product Overview
10.12.3 CombiMatrix Pre-Implantation Genetic Diagnosis (PGD) Product Market Performance
10.12.4 CombiMatrix Business Overview
10.12.5 CombiMatrix Recent Developments
11 PRE-IMPLANTATION GENETIC DIAGNOSIS (PGD) MARKET FORECAST BY REGION
11.1 Global Pre-Implantation Genetic Diagnosis (PGD) Market Size Forecast
11.2 Global Pre-Implantation Genetic Diagnosis (PGD) Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Pre-Implantation Genetic Diagnosis (PGD) Market Size Forecast by Country
11.2.3 Asia Pacific Pre-Implantation Genetic Diagnosis (PGD) Market Size Forecast by Region
11.2.4 South America Pre-Implantation Genetic Diagnosis (PGD) Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Pre-Implantation Genetic Diagnosis (PGD) by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
12.1 Global Pre-Implantation Genetic Diagnosis (PGD) Market Forecast by Type (2026-2035)
12.1.1 Global Forecasted Sales of Pre-Implantation Genetic Diagnosis (PGD) by Type (2026-2035)
12.1.2 Global Pre-Implantation Genetic Diagnosis (PGD) Market Size Forecast by Type (2026-2035)
12.1.3 Global Forecasted Price of Pre-Implantation Genetic Diagnosis (PGD) by Type (2026-2035)
12.2 Global Pre-Implantation Genetic Diagnosis (PGD) Market Forecast by Application (2026-2035)
12.2.1 Global Pre-Implantation Genetic Diagnosis (PGD) Sales (K Units) Forecast by Application
12.2.2 Global Pre-Implantation Genetic Diagnosis (PGD) Market Size (M USD) Forecast by Application (2026-2035)
13 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Pre-Implantation Genetic Diagnosis (PGD)
1.2 Key Market Segments
1.2.1 Pre-Implantation Genetic Diagnosis (PGD) Segment by Type
1.2.2 Pre-Implantation Genetic Diagnosis (PGD) Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 PRE-IMPLANTATION GENETIC DIAGNOSIS (PGD) MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Pre-Implantation Genetic Diagnosis (PGD) Market Size (M USD) Estimates and Forecasts (2020-2035)
2.1.2 Global Pre-Implantation Genetic Diagnosis (PGD) Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 PRE-IMPLANTATION GENETIC DIAGNOSIS (PGD) MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Pre-Implantation Genetic Diagnosis (PGD) Product Life Cycle
3.3 Global Pre-Implantation Genetic Diagnosis (PGD) Sales by Manufacturers (2020-2025)
3.4 Global Pre-Implantation Genetic Diagnosis (PGD) Revenue Market Share by Manufacturers (2020-2025)
3.5 Pre-Implantation Genetic Diagnosis (PGD) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Pre-Implantation Genetic Diagnosis (PGD) Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Pre-Implantation Genetic Diagnosis (PGD) Market Competitive Situation and Trends
3.8.1 Pre-Implantation Genetic Diagnosis (PGD) Market Concentration Rate
3.8.2 Global 5 and 10 Largest Pre-Implantation Genetic Diagnosis (PGD) Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 PRE-IMPLANTATION GENETIC DIAGNOSIS (PGD) INDUSTRY CHAIN ANALYSIS
4.1 Pre-Implantation Genetic Diagnosis (PGD) Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF PRE-IMPLANTATION GENETIC DIAGNOSIS (PGD) MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Pre-Implantation Genetic Diagnosis (PGD) Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Pre-Implantation Genetic Diagnosis (PGD) Market
5.7 ESG Ratings of Leading Companies
6 PRE-IMPLANTATION GENETIC DIAGNOSIS (PGD) MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Pre-Implantation Genetic Diagnosis (PGD) Sales Market Share by Type (2020-2025)
6.3 Global Pre-Implantation Genetic Diagnosis (PGD) Market Size by Type (2020-2025)
6.4 Global Pre-Implantation Genetic Diagnosis (PGD) Price by Type (2020-2025)
7 PRE-IMPLANTATION GENETIC DIAGNOSIS (PGD) MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Pre-Implantation Genetic Diagnosis (PGD) Market Sales by Application (2020-2025)
7.3 Global Pre-Implantation Genetic Diagnosis (PGD) Market Size (M USD) by Application (2020-2025)
7.4 Global Pre-Implantation Genetic Diagnosis (PGD) Sales Growth Rate by Application (2020-2025)
8 PRE-IMPLANTATION GENETIC DIAGNOSIS (PGD) MARKET SALES BY REGION
8.1 Global Pre-Implantation Genetic Diagnosis (PGD) Sales by Region
8.1.1 Global Pre-Implantation Genetic Diagnosis (PGD) Sales by Region
8.1.2 Global Pre-Implantation Genetic Diagnosis (PGD) Sales Market Share by Region
8.2 Global Pre-Implantation Genetic Diagnosis (PGD) Market Size by Region
8.2.1 Global Pre-Implantation Genetic Diagnosis (PGD) Market Size by Region
8.2.2 Global Pre-Implantation Genetic Diagnosis (PGD) Market Size by Region
8.3 North America
8.3.1 North America Pre-Implantation Genetic Diagnosis (PGD) Sales by Country
8.3.2 North America Pre-Implantation Genetic Diagnosis (PGD) Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Pre-Implantation Genetic Diagnosis (PGD) Sales by Country
8.4.2 Europe Pre-Implantation Genetic Diagnosis (PGD) Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Pre-Implantation Genetic Diagnosis (PGD) Sales by Region
8.5.2 Asia Pacific Pre-Implantation Genetic Diagnosis (PGD) Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Pre-Implantation Genetic Diagnosis (PGD) Sales by Country
8.6.2 South America Pre-Implantation Genetic Diagnosis (PGD) Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Pre-Implantation Genetic Diagnosis (PGD) Sales by Region
8.7.2 Middle East and Africa Pre-Implantation Genetic Diagnosis (PGD) Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 PRE-IMPLANTATION GENETIC DIAGNOSIS (PGD) MARKET PRODUCTION BY REGION
9.1 Global Production of Pre-Implantation Genetic Diagnosis (PGD) by Region(2020-2025)
9.2 Global Pre-Implantation Genetic Diagnosis (PGD) Revenue Market Share by Region (2020-2025)
9.3 Global Pre-Implantation Genetic Diagnosis (PGD) Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Pre-Implantation Genetic Diagnosis (PGD) Production
9.4.1 North America Pre-Implantation Genetic Diagnosis (PGD) Production Growth Rate (2020-2025)
9.4.2 North America Pre-Implantation Genetic Diagnosis (PGD) Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Pre-Implantation Genetic Diagnosis (PGD) Production
9.5.1 Europe Pre-Implantation Genetic Diagnosis (PGD) Production Growth Rate (2020-2025)
9.5.2 Europe Pre-Implantation Genetic Diagnosis (PGD) Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Pre-Implantation Genetic Diagnosis (PGD) Production (2020-2025)
9.6.1 Japan Pre-Implantation Genetic Diagnosis (PGD) Production Growth Rate (2020-2025)
9.6.2 Japan Pre-Implantation Genetic Diagnosis (PGD) Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Pre-Implantation Genetic Diagnosis (PGD) Production (2020-2025)
9.7.1 China Pre-Implantation Genetic Diagnosis (PGD) Production Growth Rate (2020-2025)
9.7.2 China Pre-Implantation Genetic Diagnosis (PGD) Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Roche
10.1.1 Roche Basic Information
10.1.2 Roche Pre-Implantation Genetic Diagnosis (PGD) Product Overview
10.1.3 Roche Pre-Implantation Genetic Diagnosis (PGD) Product Market Performance
10.1.4 Roche Business Overview
10.1.5 Roche SWOT Analysis
10.1.6 Roche Recent Developments
10.2 Genea Limited
10.2.1 Genea Limited Basic Information
10.2.2 Genea Limited Pre-Implantation Genetic Diagnosis (PGD) Product Overview
10.2.3 Genea Limited Pre-Implantation Genetic Diagnosis (PGD) Product Market Performance
10.2.4 Genea Limited Business Overview
10.2.5 Genea Limited SWOT Analysis
10.2.6 Genea Limited Recent Developments
10.3 Quest Diagnostics
10.3.1 Quest Diagnostics Basic Information
10.3.2 Quest Diagnostics Pre-Implantation Genetic Diagnosis (PGD) Product Overview
10.3.3 Quest Diagnostics Pre-Implantation Genetic Diagnosis (PGD) Product Market Performance
10.3.4 Quest Diagnostics Business Overview
10.3.5 Quest Diagnostics SWOT Analysis
10.3.6 Quest Diagnostics Recent Developments
10.4 Illumina, Inc.
10.4.1 Illumina, Inc. Basic Information
10.4.2 Illumina, Inc. Pre-Implantation Genetic Diagnosis (PGD) Product Overview
10.4.3 Illumina, Inc. Pre-Implantation Genetic Diagnosis (PGD) Product Market Performance
10.4.4 Illumina, Inc. Business Overview
10.4.5 Illumina, Inc. Recent Developments
10.5 Natera, Inc.
10.5.1 Natera, Inc. Basic Information
10.5.2 Natera, Inc. Pre-Implantation Genetic Diagnosis (PGD) Product Overview
10.5.3 Natera, Inc. Pre-Implantation Genetic Diagnosis (PGD) Product Market Performance
10.5.4 Natera, Inc. Business Overview
10.5.5 Natera, Inc. Recent Developments
10.6 Cooper Medical, Inc.
10.6.1 Cooper Medical, Inc. Basic Information
10.6.2 Cooper Medical, Inc. Pre-Implantation Genetic Diagnosis (PGD) Product Overview
10.6.3 Cooper Medical, Inc. Pre-Implantation Genetic Diagnosis (PGD) Product Market Performance
10.6.4 Cooper Medical, Inc. Business Overview
10.6.5 Cooper Medical, Inc. Recent Developments
10.7 LabCorp
10.7.1 LabCorp Basic Information
10.7.2 LabCorp Pre-Implantation Genetic Diagnosis (PGD) Product Overview
10.7.3 LabCorp Pre-Implantation Genetic Diagnosis (PGD) Product Market Performance
10.7.4 LabCorp Business Overview
10.7.5 LabCorp Recent Developments
10.8 California Pacific Medical Center (CPMC)
10.8.1 California Pacific Medical Center (CPMC) Basic Information
10.8.2 California Pacific Medical Center (CPMC) Pre-Implantation Genetic Diagnosis (PGD) Product Overview
10.8.3 California Pacific Medical Center (CPMC) Pre-Implantation Genetic Diagnosis (PGD) Product Market Performance
10.8.4 California Pacific Medical Center (CPMC) Business Overview
10.8.5 California Pacific Medical Center (CPMC) Recent Developments
10.9 Thermo Fisher Scientific Inc.
10.9.1 Thermo Fisher Scientific Inc. Basic Information
10.9.2 Thermo Fisher Scientific Inc. Pre-Implantation Genetic Diagnosis (PGD) Product Overview
10.9.3 Thermo Fisher Scientific Inc. Pre-Implantation Genetic Diagnosis (PGD) Product Market Performance
10.9.4 Thermo Fisher Scientific Inc. Business Overview
10.9.5 Thermo Fisher Scientific Inc. Recent Developments
10.10 IGENOMIX
10.10.1 IGENOMIX Basic Information
10.10.2 IGENOMIX Pre-Implantation Genetic Diagnosis (PGD) Product Overview
10.10.3 IGENOMIX Pre-Implantation Genetic Diagnosis (PGD) Product Market Performance
10.10.4 IGENOMIX Business Overview
10.10.5 IGENOMIX Recent Developments
10.11 Reproductive Genetic Innovations
10.11.1 Reproductive Genetic Innovations Basic Information
10.11.2 Reproductive Genetic Innovations Pre-Implantation Genetic Diagnosis (PGD) Product Overview
10.11.3 Reproductive Genetic Innovations Pre-Implantation Genetic Diagnosis (PGD) Product Market Performance
10.11.4 Reproductive Genetic Innovations Business Overview
10.11.5 Reproductive Genetic Innovations Recent Developments
10.12 CombiMatrix
10.12.1 CombiMatrix Basic Information
10.12.2 CombiMatrix Pre-Implantation Genetic Diagnosis (PGD) Product Overview
10.12.3 CombiMatrix Pre-Implantation Genetic Diagnosis (PGD) Product Market Performance
10.12.4 CombiMatrix Business Overview
10.12.5 CombiMatrix Recent Developments
11 PRE-IMPLANTATION GENETIC DIAGNOSIS (PGD) MARKET FORECAST BY REGION
11.1 Global Pre-Implantation Genetic Diagnosis (PGD) Market Size Forecast
11.2 Global Pre-Implantation Genetic Diagnosis (PGD) Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Pre-Implantation Genetic Diagnosis (PGD) Market Size Forecast by Country
11.2.3 Asia Pacific Pre-Implantation Genetic Diagnosis (PGD) Market Size Forecast by Region
11.2.4 South America Pre-Implantation Genetic Diagnosis (PGD) Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Pre-Implantation Genetic Diagnosis (PGD) by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
12.1 Global Pre-Implantation Genetic Diagnosis (PGD) Market Forecast by Type (2026-2035)
12.1.1 Global Forecasted Sales of Pre-Implantation Genetic Diagnosis (PGD) by Type (2026-2035)
12.1.2 Global Pre-Implantation Genetic Diagnosis (PGD) Market Size Forecast by Type (2026-2035)
12.1.3 Global Forecasted Price of Pre-Implantation Genetic Diagnosis (PGD) by Type (2026-2035)
12.2 Global Pre-Implantation Genetic Diagnosis (PGD) Market Forecast by Application (2026-2035)
12.2.1 Global Pre-Implantation Genetic Diagnosis (PGD) Sales (K Units) Forecast by Application
12.2.2 Global Pre-Implantation Genetic Diagnosis (PGD) Market Size (M USD) Forecast by Application (2026-2035)
13 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Pre-Implantation Genetic Diagnosis (PGD) Market Size by Type (M USD)
Table 4. Global Pre-Implantation Genetic Diagnosis (PGD) Market Size by Application
Table 5. Pre-Implantation Genetic Diagnosis (PGD) Market Size Comparison by Region (M USD)
Table 6. Global Pre-Implantation Genetic Diagnosis (PGD) Sales (K Units) by Manufacturers (2020-2025)
Table 7. Global Pre-Implantation Genetic Diagnosis (PGD) Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Pre-Implantation Genetic Diagnosis (PGD) Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Pre-Implantation Genetic Diagnosis (PGD) Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pre-Implantation Genetic Diagnosis (PGD) as of 2025)
Table 11. Global Market Pre-Implantation Genetic Diagnosis (PGD) Average Price (USD/Unit) of Key Manufacturers (2020-2025)
Table 12. Manufacturers? Manufacturing Sites, Areas Served
Table 13. Manufacturers? Product Type
Table 14. Global Pre-Implantation Genetic Diagnosis (PGD) Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Pre-Implantation Genetic Diagnosis (PGD) Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global Pre-Implantation Genetic Diagnosis (PGD) Sales by Type (K Units)
Table 27. Global Pre-Implantation Genetic Diagnosis (PGD) Market Size by Type (M USD)
Table 28. Global Pre-Implantation Genetic Diagnosis (PGD) Sales (K Units) by Type (2020-2025)
Table 29. Global Pre-Implantation Genetic Diagnosis (PGD) Sales Market Share by Type (2020-2025)
Table 30. Global Pre-Implantation Genetic Diagnosis (PGD) Market Size (M USD) by Type (2020-2025)
Table 31. Global Pre-Implantation Genetic Diagnosis (PGD) Market Share by Type (2020-2025)
Table 32. Global Pre-Implantation Genetic Diagnosis (PGD) Price (USD/Unit) by Type (2020-2025)
Table 33. Global Pre-Implantation Genetic Diagnosis (PGD) Sales (K Units) by Application
Table 34. Global Pre-Implantation Genetic Diagnosis (PGD) Market Size by Application
Table 35. Global Pre-Implantation Genetic Diagnosis (PGD) Sales by Application (2020-2025) & (K Units)
Table 36. Global Pre-Implantation Genetic Diagnosis (PGD) Sales Market Share by Application (2020-2025)
Table 37. Global Pre-Implantation Genetic Diagnosis (PGD) Market Size by Application (2020-2025) & (M USD)
Table 38. Global Pre-Implantation Genetic Diagnosis (PGD) Market Share by Application (2020-2025)
Table 39. Global Pre-Implantation Genetic Diagnosis (PGD) Sales Growth Rate by Application (2020-2025)
Table 40. Global Pre-Implantation Genetic Diagnosis (PGD) Sales by Region (2020-2025) & (K Units)
Table 41. Global Pre-Implantation Genetic Diagnosis (PGD) Sales Market Share by Region (2020-2025)
Table 42. Global Pre-Implantation Genetic Diagnosis (PGD) Market Size by Region (2020-2025) & (M USD)
Table 43. Global Pre-Implantation Genetic Diagnosis (PGD) Market Size by Region (2020-2025)
Table 44. North America Pre-Implantation Genetic Diagnosis (PGD) Sales by Country (2020-2025) & (K Units)
Table 45. North America Pre-Implantation Genetic Diagnosis (PGD) Market Size by Country (2020-2025) & (M USD)
Table 46. Europe Pre-Implantation Genetic Diagnosis (PGD) Sales by Country (2020-2025) & (K Units)
Table 47. Europe Pre-Implantation Genetic Diagnosis (PGD) Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific Pre-Implantation Genetic Diagnosis (PGD) Sales by Region (2020-2025) & (K Units)
Table 49. Asia Pacific Pre-Implantation Genetic Diagnosis (PGD) Market Size by Region (2020-2025) & (M USD)
Table 50. South America Pre-Implantation Genetic Diagnosis (PGD) Sales by Country (2020-2025) & (K Units)
Table 51. South America Pre-Implantation Genetic Diagnosis (PGD) Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa Pre-Implantation Genetic Diagnosis (PGD) Sales by Region (2020-2025) & (K Units)
Table 53. Middle East and Africa Pre-Implantation Genetic Diagnosis (PGD) Market Size by Region (2020-2025) & (M USD)
Table 54. Global Pre-Implantation Genetic Diagnosis (PGD) Production (K Units) by Region(2020-2025)
Table 55. Global Pre-Implantation Genetic Diagnosis (PGD) Revenue (US$ Million) by Region (2020-2025)
Table 56. Global Pre-Implantation Genetic Diagnosis (PGD) Revenue Market Share by Region (2020-2025)
Table 57. Global Pre-Implantation Genetic Diagnosis (PGD) Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 58. North America Pre-Implantation Genetic Diagnosis (PGD) Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 59. Europe Pre-Implantation Genetic Diagnosis (PGD) Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 60. Japan Pre-Implantation Genetic Diagnosis (PGD) Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 61. China Pre-Implantation Genetic Diagnosis (PGD) Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 62. Roche Basic Information
Table 63. Roche Pre-Implantation Genetic Diagnosis (PGD) Product Overview
Table 64. Roche Pre-Implantation Genetic Diagnosis (PGD) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 65. Roche Business Overview
Table 66. Roche SWOT Analysis
Table 67. Roche Recent Developments
Table 68. Genea Limited Basic Information
Table 69. Genea Limited Pre-Implantation Genetic Diagnosis (PGD) Product Overview
Table 70. Genea Limited Pre-Implantation Genetic Diagnosis (PGD) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 71. Genea Limited Business Overview
Table 72. Genea Limited SWOT Analysis
Table 73. Genea Limited Recent Developments
Table 74. Quest Diagnostics Basic Information
Table 75. Quest Diagnostics Pre-Implantation Genetic Diagnosis (PGD) Product Overview
Table 76. Quest Diagnostics Pre-Implantation Genetic Diagnosis (PGD) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 77. Quest Diagnostics Business Overview
Table 78. Quest Diagnostics SWOT Analysis
Table 79. Quest Diagnostics Recent Developments
Table 80. Illumina, Inc. Basic Information
Table 81. Illumina, Inc. Pre-Implantation Genetic Diagnosis (PGD) Product Overview
Table 82. Illumina, Inc. Pre-Implantation Genetic Diagnosis (PGD) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 83. Illumina, Inc. Business Overview
Table 84. Illumina, Inc. Recent Developments
Table 85. Natera, Inc. Basic Information
Table 86. Natera, Inc. Pre-Implantation Genetic Diagnosis (PGD) Product Overview
Table 87. Natera, Inc. Pre-Implantation Genetic Diagnosis (PGD) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 88. Natera, Inc. Business Overview
Table 89. Natera, Inc. Recent Developments
Table 90. Cooper Medical, Inc. Basic Information
Table 91. Cooper Medical, Inc. Pre-Implantation Genetic Diagnosis (PGD) Product Overview
Table 92. Cooper Medical, Inc. Pre-Implantation Genetic Diagnosis (PGD) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 93. Cooper Medical, Inc. Business Overview
Table 94. Cooper Medical, Inc. Recent Developments
Table 95. LabCorp Basic Information
Table 96. LabCorp Pre-Implantation Genetic Diagnosis (PGD) Product Overview
Table 97. LabCorp Pre-Implantation Genetic Diagnosis (PGD) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 98. LabCorp Business Overview
Table 99. LabCorp Recent Developments
Table 100. California Pacific Medical Center (CPMC) Basic Information
Table 101. California Pacific Medical Center (CPMC) Pre-Implantation Genetic Diagnosis (PGD) Product Overview
Table 102. California Pacific Medical Center (CPMC) Pre-Implantation Genetic Diagnosis (PGD) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 103. California Pacific Medical Center (CPMC) Business Overview
Table 104. California Pacific Medical Center (CPMC) Recent Developments
Table 105. Thermo Fisher Scientific Inc. Basic Information
Table 106. Thermo Fisher Scientific Inc. Pre-Implantation Genetic Diagnosis (PGD) Product Overview
Table 107. Thermo Fisher Scientific Inc. Pre-Implantation Genetic Diagnosis (PGD) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 108. Thermo Fisher Scientific Inc. Business Overview
Table 109. Thermo Fisher Scientific Inc. Recent Developments
Table 110. IGENOMIX Basic Information
Table 111. IGENOMIX Pre-Implantation Genetic Diagnosis (PGD) Product Overview
Table 112. IGENOMIX Pre-Implantation Genetic Diagnosis (PGD) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 113. IGENOMIX Business Overview
Table 114. IGENOMIX Recent Developments
Table 115. Reproductive Genetic Innovations Basic Information
Table 116. Reproductive Genetic Innovations Pre-Implantation Genetic Diagnosis (PGD) Product Overview
Table 117. Reproductive Genetic Innovations Pre-Implantation Genetic Diagnosis (PGD) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 118. Reproductive Genetic Innovations Business Overview
Table 119. Reproductive Genetic Innovations Recent Developments
Table 120. CombiMatrix Basic Information
Table 121. CombiMatrix Pre-Implantation Genetic Diagnosis (PGD) Product Overview
Table 122. CombiMatrix Pre-Implantation Genetic Diagnosis (PGD) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 123. CombiMatrix Business Overview
Table 124. CombiMatrix Recent Developments
Table 125. Global Pre-Implantation Genetic Diagnosis (PGD) Sales Forecast by Region (2026-2035) & (K Units)
Table 126. Global Pre-Implantation Genetic Diagnosis (PGD) Market Size Forecast by Region (2026-2035) & (M USD)
Table 127. North America Pre-Implantation Genetic Diagnosis (PGD) Sales Forecast by Country (2026-2035) & (K Units)
Table 128. North America Pre-Implantation Genetic Diagnosis (PGD) Market Size Forecast by Country (2026-2035) & (M USD)
Table 129. Europe Pre-Implantation Genetic Diagnosis (PGD) Sales Forecast by Country (2026-2035) & (K Units)
Table 130. Europe Pre-Implantation Genetic Diagnosis (PGD) Market Size Forecast by Country (2026-2035) & (M USD)
Table 131. Asia Pacific Pre-Implantation Genetic Diagnosis (PGD) Sales Forecast by Region (2026-2035) & (K Units)
Table 132. Asia Pacific Pre-Implantation Genetic Diagnosis (PGD) Market Size Forecast by Region (2026-2035) & (M USD)
Table 133. South America Pre-Implantation Genetic Diagnosis (PGD) Sales Forecast by Country (2026-2035) & (K Units)
Table 134. South America Pre-Implantation Genetic Diagnosis (PGD) Market Size Forecast by Country (2026-2035) & (M USD)
Table 135. Middle East and Africa Pre-Implantation Genetic Diagnosis (PGD) Sales Forecast by Country (2026-2035) & (Units)
Table 136. Middle East and Africa Pre-Implantation Genetic Diagnosis (PGD) Market Size Forecast by Country (2026-2035) & (M USD)
Table 137. Global Pre-Implantation Genetic Diagnosis (PGD) Sales Forecast by Type (2026-2035) & (K Units)
Table 138. Global Pre-Implantation Genetic Diagnosis (PGD) Market Size Forecast by Type (2026-2035) & (M USD)
Table 139. Global Pre-Implantation Genetic Diagnosis (PGD) Price Forecast by Type (2026-2035) & (USD/Unit)
Table 140. Global Pre-Implantation Genetic Diagnosis (PGD) Sales (K Units) Forecast by Application (2026-2035)
Table 141. Global Pre-Implantation Genetic Diagnosis (PGD) Market Size Forecast by Application (2026-2035) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Pre-Implantation Genetic Diagnosis (PGD) Market Size by Type (M USD)
Table 4. Global Pre-Implantation Genetic Diagnosis (PGD) Market Size by Application
Table 5. Pre-Implantation Genetic Diagnosis (PGD) Market Size Comparison by Region (M USD)
Table 6. Global Pre-Implantation Genetic Diagnosis (PGD) Sales (K Units) by Manufacturers (2020-2025)
Table 7. Global Pre-Implantation Genetic Diagnosis (PGD) Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Pre-Implantation Genetic Diagnosis (PGD) Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Pre-Implantation Genetic Diagnosis (PGD) Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pre-Implantation Genetic Diagnosis (PGD) as of 2025)
Table 11. Global Market Pre-Implantation Genetic Diagnosis (PGD) Average Price (USD/Unit) of Key Manufacturers (2020-2025)
Table 12. Manufacturers? Manufacturing Sites, Areas Served
Table 13. Manufacturers? Product Type
Table 14. Global Pre-Implantation Genetic Diagnosis (PGD) Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Pre-Implantation Genetic Diagnosis (PGD) Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global Pre-Implantation Genetic Diagnosis (PGD) Sales by Type (K Units)
Table 27. Global Pre-Implantation Genetic Diagnosis (PGD) Market Size by Type (M USD)
Table 28. Global Pre-Implantation Genetic Diagnosis (PGD) Sales (K Units) by Type (2020-2025)
Table 29. Global Pre-Implantation Genetic Diagnosis (PGD) Sales Market Share by Type (2020-2025)
Table 30. Global Pre-Implantation Genetic Diagnosis (PGD) Market Size (M USD) by Type (2020-2025)
Table 31. Global Pre-Implantation Genetic Diagnosis (PGD) Market Share by Type (2020-2025)
Table 32. Global Pre-Implantation Genetic Diagnosis (PGD) Price (USD/Unit) by Type (2020-2025)
Table 33. Global Pre-Implantation Genetic Diagnosis (PGD) Sales (K Units) by Application
Table 34. Global Pre-Implantation Genetic Diagnosis (PGD) Market Size by Application
Table 35. Global Pre-Implantation Genetic Diagnosis (PGD) Sales by Application (2020-2025) & (K Units)
Table 36. Global Pre-Implantation Genetic Diagnosis (PGD) Sales Market Share by Application (2020-2025)
Table 37. Global Pre-Implantation Genetic Diagnosis (PGD) Market Size by Application (2020-2025) & (M USD)
Table 38. Global Pre-Implantation Genetic Diagnosis (PGD) Market Share by Application (2020-2025)
Table 39. Global Pre-Implantation Genetic Diagnosis (PGD) Sales Growth Rate by Application (2020-2025)
Table 40. Global Pre-Implantation Genetic Diagnosis (PGD) Sales by Region (2020-2025) & (K Units)
Table 41. Global Pre-Implantation Genetic Diagnosis (PGD) Sales Market Share by Region (2020-2025)
Table 42. Global Pre-Implantation Genetic Diagnosis (PGD) Market Size by Region (2020-2025) & (M USD)
Table 43. Global Pre-Implantation Genetic Diagnosis (PGD) Market Size by Region (2020-2025)
Table 44. North America Pre-Implantation Genetic Diagnosis (PGD) Sales by Country (2020-2025) & (K Units)
Table 45. North America Pre-Implantation Genetic Diagnosis (PGD) Market Size by Country (2020-2025) & (M USD)
Table 46. Europe Pre-Implantation Genetic Diagnosis (PGD) Sales by Country (2020-2025) & (K Units)
Table 47. Europe Pre-Implantation Genetic Diagnosis (PGD) Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific Pre-Implantation Genetic Diagnosis (PGD) Sales by Region (2020-2025) & (K Units)
Table 49. Asia Pacific Pre-Implantation Genetic Diagnosis (PGD) Market Size by Region (2020-2025) & (M USD)
Table 50. South America Pre-Implantation Genetic Diagnosis (PGD) Sales by Country (2020-2025) & (K Units)
Table 51. South America Pre-Implantation Genetic Diagnosis (PGD) Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa Pre-Implantation Genetic Diagnosis (PGD) Sales by Region (2020-2025) & (K Units)
Table 53. Middle East and Africa Pre-Implantation Genetic Diagnosis (PGD) Market Size by Region (2020-2025) & (M USD)
Table 54. Global Pre-Implantation Genetic Diagnosis (PGD) Production (K Units) by Region(2020-2025)
Table 55. Global Pre-Implantation Genetic Diagnosis (PGD) Revenue (US$ Million) by Region (2020-2025)
Table 56. Global Pre-Implantation Genetic Diagnosis (PGD) Revenue Market Share by Region (2020-2025)
Table 57. Global Pre-Implantation Genetic Diagnosis (PGD) Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 58. North America Pre-Implantation Genetic Diagnosis (PGD) Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 59. Europe Pre-Implantation Genetic Diagnosis (PGD) Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 60. Japan Pre-Implantation Genetic Diagnosis (PGD) Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 61. China Pre-Implantation Genetic Diagnosis (PGD) Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 62. Roche Basic Information
Table 63. Roche Pre-Implantation Genetic Diagnosis (PGD) Product Overview
Table 64. Roche Pre-Implantation Genetic Diagnosis (PGD) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 65. Roche Business Overview
Table 66. Roche SWOT Analysis
Table 67. Roche Recent Developments
Table 68. Genea Limited Basic Information
Table 69. Genea Limited Pre-Implantation Genetic Diagnosis (PGD) Product Overview
Table 70. Genea Limited Pre-Implantation Genetic Diagnosis (PGD) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 71. Genea Limited Business Overview
Table 72. Genea Limited SWOT Analysis
Table 73. Genea Limited Recent Developments
Table 74. Quest Diagnostics Basic Information
Table 75. Quest Diagnostics Pre-Implantation Genetic Diagnosis (PGD) Product Overview
Table 76. Quest Diagnostics Pre-Implantation Genetic Diagnosis (PGD) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 77. Quest Diagnostics Business Overview
Table 78. Quest Diagnostics SWOT Analysis
Table 79. Quest Diagnostics Recent Developments
Table 80. Illumina, Inc. Basic Information
Table 81. Illumina, Inc. Pre-Implantation Genetic Diagnosis (PGD) Product Overview
Table 82. Illumina, Inc. Pre-Implantation Genetic Diagnosis (PGD) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 83. Illumina, Inc. Business Overview
Table 84. Illumina, Inc. Recent Developments
Table 85. Natera, Inc. Basic Information
Table 86. Natera, Inc. Pre-Implantation Genetic Diagnosis (PGD) Product Overview
Table 87. Natera, Inc. Pre-Implantation Genetic Diagnosis (PGD) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 88. Natera, Inc. Business Overview
Table 89. Natera, Inc. Recent Developments
Table 90. Cooper Medical, Inc. Basic Information
Table 91. Cooper Medical, Inc. Pre-Implantation Genetic Diagnosis (PGD) Product Overview
Table 92. Cooper Medical, Inc. Pre-Implantation Genetic Diagnosis (PGD) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 93. Cooper Medical, Inc. Business Overview
Table 94. Cooper Medical, Inc. Recent Developments
Table 95. LabCorp Basic Information
Table 96. LabCorp Pre-Implantation Genetic Diagnosis (PGD) Product Overview
Table 97. LabCorp Pre-Implantation Genetic Diagnosis (PGD) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 98. LabCorp Business Overview
Table 99. LabCorp Recent Developments
Table 100. California Pacific Medical Center (CPMC) Basic Information
Table 101. California Pacific Medical Center (CPMC) Pre-Implantation Genetic Diagnosis (PGD) Product Overview
Table 102. California Pacific Medical Center (CPMC) Pre-Implantation Genetic Diagnosis (PGD) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 103. California Pacific Medical Center (CPMC) Business Overview
Table 104. California Pacific Medical Center (CPMC) Recent Developments
Table 105. Thermo Fisher Scientific Inc. Basic Information
Table 106. Thermo Fisher Scientific Inc. Pre-Implantation Genetic Diagnosis (PGD) Product Overview
Table 107. Thermo Fisher Scientific Inc. Pre-Implantation Genetic Diagnosis (PGD) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 108. Thermo Fisher Scientific Inc. Business Overview
Table 109. Thermo Fisher Scientific Inc. Recent Developments
Table 110. IGENOMIX Basic Information
Table 111. IGENOMIX Pre-Implantation Genetic Diagnosis (PGD) Product Overview
Table 112. IGENOMIX Pre-Implantation Genetic Diagnosis (PGD) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 113. IGENOMIX Business Overview
Table 114. IGENOMIX Recent Developments
Table 115. Reproductive Genetic Innovations Basic Information
Table 116. Reproductive Genetic Innovations Pre-Implantation Genetic Diagnosis (PGD) Product Overview
Table 117. Reproductive Genetic Innovations Pre-Implantation Genetic Diagnosis (PGD) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 118. Reproductive Genetic Innovations Business Overview
Table 119. Reproductive Genetic Innovations Recent Developments
Table 120. CombiMatrix Basic Information
Table 121. CombiMatrix Pre-Implantation Genetic Diagnosis (PGD) Product Overview
Table 122. CombiMatrix Pre-Implantation Genetic Diagnosis (PGD) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 123. CombiMatrix Business Overview
Table 124. CombiMatrix Recent Developments
Table 125. Global Pre-Implantation Genetic Diagnosis (PGD) Sales Forecast by Region (2026-2035) & (K Units)
Table 126. Global Pre-Implantation Genetic Diagnosis (PGD) Market Size Forecast by Region (2026-2035) & (M USD)
Table 127. North America Pre-Implantation Genetic Diagnosis (PGD) Sales Forecast by Country (2026-2035) & (K Units)
Table 128. North America Pre-Implantation Genetic Diagnosis (PGD) Market Size Forecast by Country (2026-2035) & (M USD)
Table 129. Europe Pre-Implantation Genetic Diagnosis (PGD) Sales Forecast by Country (2026-2035) & (K Units)
Table 130. Europe Pre-Implantation Genetic Diagnosis (PGD) Market Size Forecast by Country (2026-2035) & (M USD)
Table 131. Asia Pacific Pre-Implantation Genetic Diagnosis (PGD) Sales Forecast by Region (2026-2035) & (K Units)
Table 132. Asia Pacific Pre-Implantation Genetic Diagnosis (PGD) Market Size Forecast by Region (2026-2035) & (M USD)
Table 133. South America Pre-Implantation Genetic Diagnosis (PGD) Sales Forecast by Country (2026-2035) & (K Units)
Table 134. South America Pre-Implantation Genetic Diagnosis (PGD) Market Size Forecast by Country (2026-2035) & (M USD)
Table 135. Middle East and Africa Pre-Implantation Genetic Diagnosis (PGD) Sales Forecast by Country (2026-2035) & (Units)
Table 136. Middle East and Africa Pre-Implantation Genetic Diagnosis (PGD) Market Size Forecast by Country (2026-2035) & (M USD)
Table 137. Global Pre-Implantation Genetic Diagnosis (PGD) Sales Forecast by Type (2026-2035) & (K Units)
Table 138. Global Pre-Implantation Genetic Diagnosis (PGD) Market Size Forecast by Type (2026-2035) & (M USD)
Table 139. Global Pre-Implantation Genetic Diagnosis (PGD) Price Forecast by Type (2026-2035) & (USD/Unit)
Table 140. Global Pre-Implantation Genetic Diagnosis (PGD) Sales (K Units) Forecast by Application (2026-2035)
Table 141. Global Pre-Implantation Genetic Diagnosis (PGD) Market Size Forecast by Application (2026-2035) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Pre-Implantation Genetic Diagnosis (PGD)
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Pre-Implantation Genetic Diagnosis (PGD) Market Size (M USD), 2025-2035
Figure 5. Global Pre-Implantation Genetic Diagnosis (PGD) Market Size (M USD) (2020-2035)
Figure 6. Global Pre-Implantation Genetic Diagnosis (PGD) Sales (K Units) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Pre-Implantation Genetic Diagnosis (PGD) Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Pre-Implantation Genetic Diagnosis (PGD) Product Life Cycle
Figure 13. Pre-Implantation Genetic Diagnosis (PGD) Sales Share by Manufacturers in 2025
Figure 14. Global Pre-Implantation Genetic Diagnosis (PGD) Revenue Share by Manufacturers in 2025
Figure 15. Pre-Implantation Genetic Diagnosis (PGD) Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market Pre-Implantation Genetic Diagnosis (PGD) Average Price (USD/Unit) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by Pre-Implantation Genetic Diagnosis (PGD) Revenue in 2025
Figure 18. Industry Chain Map of Pre-Implantation Genetic Diagnosis (PGD)
Figure 19. Global Pre-Implantation Genetic Diagnosis (PGD) Market PEST Analysis
Figure 20. Global Pre-Implantation Genetic Diagnosis (PGD) Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Pre-Implantation Genetic Diagnosis (PGD) Market Share by Type
Figure 27. Sales Market Share of Pre-Implantation Genetic Diagnosis (PGD) by Type (2020-2025)
Figure 28. Sales Market Share of Pre-Implantation Genetic Diagnosis (PGD) by Type in 2025
Figure 29. Market Share of Pre-Implantation Genetic Diagnosis (PGD) by Type (2020-2025)
Figure 30. Market Share of Pre-Implantation Genetic Diagnosis (PGD) by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Pre-Implantation Genetic Diagnosis (PGD) Market Share by Application
Figure 33. Global Pre-Implantation Genetic Diagnosis (PGD) Sales Market Share by Application (2020-2025)
Figure 34. Global Pre-Implantation Genetic Diagnosis (PGD) Sales Market Share by Application in 2025
Figure 35. Global Pre-Implantation Genetic Diagnosis (PGD) Market Share by Application (2020-2025)
Figure 36. Global Pre-Implantation Genetic Diagnosis (PGD) Market Share by Application in 2025
Figure 37. Global Pre-Implantation Genetic Diagnosis (PGD) Sales Growth Rate by Application (2020-2025)
Figure 38. Global Pre-Implantation Genetic Diagnosis (PGD) Sales Market Share by Region (2020-2025)
Figure 39. Global Pre-Implantation Genetic Diagnosis (PGD) Market Size by Region (2020-2025)
Figure 40. North America Pre-Implantation Genetic Diagnosis (PGD) Sales and Growth Rate (2020-2025) & (K Units)
Figure 41. North America Pre-Implantation Genetic Diagnosis (PGD) Sales and Growth Rate (2020-2025) & (K Units)
Figure 42. North America Pre-Implantation Genetic Diagnosis (PGD) Sales Market Share by Country in 2024
Figure 43. North America Pre-Implantation Genetic Diagnosis (PGD) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Pre-Implantation Genetic Diagnosis (PGD) Market Size by Country in 2024
Figure 45. U.S. Pre-Implantation Genetic Diagnosis (PGD) Sales and Growth Rate (2020-2025) & (K Units)
Figure 46. U.S. Pre-Implantation Genetic Diagnosis (PGD) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Pre-Implantation Genetic Diagnosis (PGD) Sales (K Units) and Growth Rate (2020-2025)
Figure 48. Canada Pre-Implantation Genetic Diagnosis (PGD) Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Pre-Implantation Genetic Diagnosis (PGD) Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Pre-Implantation Genetic Diagnosis (PGD) Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Pre-Implantation Genetic Diagnosis (PGD) Sales and Growth Rate (2020-2025) & (K Units)
Figure 52. Europe Pre-Implantation Genetic Diagnosis (PGD) Sales Market Share by Country in 2024
Figure 53. Europe Pre-Implantation Genetic Diagnosis (PGD) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Pre-Implantation Genetic Diagnosis (PGD) Market Size by Country in 2024
Figure 55. Germany Pre-Implantation Genetic Diagnosis (PGD) Sales and Growth Rate (2020-2025) & (K Units)
Figure 56. Germany Pre-Implantation Genetic Diagnosis (PGD) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Pre-Implantation Genetic Diagnosis (PGD) Sales and Growth Rate (2020-2025) & (K Units)
Figure 58. France Pre-Implantation Genetic Diagnosis (PGD) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Pre-Implantation Genetic Diagnosis (PGD) Sales and Growth Rate (2020-2025) & (K Units)
Figure 60. U.K. Pre-Implantation Genetic Diagnosis (PGD) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Pre-Implantation Genetic Diagnosis (PGD) Sales and Growth Rate (2020-2025) & (K Units)
Figure 62. Italy Pre-Implantation Genetic Diagnosis (PGD) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Pre-Implantation Genetic Diagnosis (PGD) Sales and Growth Rate (2020-2025) & (K Units)
Figure 64. Spain Pre-Implantation Genetic Diagnosis (PGD) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Pre-Implantation Genetic Diagnosis (PGD) Sales and Growth Rate (K Units)
Figure 66. Asia Pacific Pre-Implantation Genetic Diagnosis (PGD) Sales Market Share by Region in 2024
Figure 67. Asia Pacific Pre-Implantation Genetic Diagnosis (PGD) Market Size by Region in 2024
Figure 68. China Pre-Implantation Genetic Diagnosis (PGD) Sales and Growth Rate (2020-2025) & (K Units)
Figure 69. China Pre-Implantation Genetic Diagnosis (PGD) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Pre-Implantation Genetic Diagnosis (PGD) Sales and Growth Rate (2020-2025) & (K Units)
Figure 71. Japan Pre-Implantation Genetic Diagnosis (PGD) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Pre-Implantation Genetic Diagnosis (PGD) Sales and Growth Rate (2020-2025) & (K Units)
Figure 73. South Korea Pre-Implantation Genetic Diagnosis (PGD) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Pre-Implantation Genetic Diagnosis (PGD) Sales and Growth Rate (2020-2025) & (K Units)
Figure 75. India Pre-Implantation Genetic Diagnosis (PGD) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Pre-Implantation Genetic Diagnosis (PGD) Sales and Growth Rate (2020-2025) & (K Units)
Figure 77. Southeast Asia Pre-Implantation Genetic Diagnosis (PGD) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Pre-Implantation Genetic Diagnosis (PGD) Sales and Growth Rate (K Units)
Figure 79. South America Pre-Implantation Genetic Diagnosis (PGD) Sales Market Share by Country in 2024
Figure 80. South America Pre-Implantation Genetic Diagnosis (PGD) Market Size and Growth Rate (M USD)
Figure 81. South America Pre-Implantation Genetic Diagnosis (PGD) Market Size by Country in 2024
Figure 82. Brazil Pre-Implantation Genetic Diagnosis (PGD) Sales and Growth Rate (2020-2025) & (K Units)
Figure 83. Brazil Pre-Implantation Genetic Diagnosis (PGD) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Pre-Implantation Genetic Diagnosis (PGD) Sales and Growth Rate (2020-2025) & (K Units)
Figure 85. Argentina Pre-Implantation Genetic Diagnosis (PGD) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Pre-Implantation Genetic Diagnosis (PGD) Sales and Growth Rate (2020-2025) & (K Units)
Figure 87. Columbia Pre-Implantation Genetic Diagnosis (PGD) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Pre-Implantation Genetic Diagnosis (PGD) Sales and Growth Rate (K Units)
Figure 89. Middle East and Africa Pre-Implantation Genetic Diagnosis (PGD) Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Pre-Implantation Genetic Diagnosis (PGD) Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Pre-Implantation Genetic Diagnosis (PGD) Market Size by Region in 2024
Figure 92. Saudi Arabia Pre-Implantation Genetic Diagnosis (PGD) Sales and Growth Rate (2020-2025) & (K Units)
Figure 93. Saudi Arabia Pre-Implantation Genetic Diagnosis (PGD) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Pre-Implantation Genetic Diagnosis (PGD) Sales and Growth Rate (2020-2025) & (K Units)
Figure 95. UAE Pre-Implantation Genetic Diagnosis (PGD) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Pre-Implantation Genetic Diagnosis (PGD) Sales and Growth Rate (2020-2025) & (K Units)
Figure 97. Egypt Pre-Implantation Genetic Diagnosis (PGD) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Pre-Implantation Genetic Diagnosis (PGD) Sales and Growth Rate (2020-2025) & (K Units)
Figure 99. Nigeria Pre-Implantation Genetic Diagnosis (PGD) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Pre-Implantation Genetic Diagnosis (PGD) Sales and Growth Rate (2020-2025) & (K Units)
Figure 101. South Africa Pre-Implantation Genetic Diagnosis (PGD) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Pre-Implantation Genetic Diagnosis (PGD) Production Market Share by Region (2020-2025)
Figure 103. North America Pre-Implantation Genetic Diagnosis (PGD) Production (K Units) Growth Rate (2020-2025)
Figure 104. Europe Pre-Implantation Genetic Diagnosis (PGD) Production (K Units) Growth Rate (2020-2025)
Figure 105. Japan Pre-Implantation Genetic Diagnosis (PGD) Production (K Units) Growth Rate (2020-2025)
Figure 106. China Pre-Implantation Genetic Diagnosis (PGD) Production (K Units) Growth Rate (2020-2025)
Figure 107. Global Pre-Implantation Genetic Diagnosis (PGD) Sales Forecast by Volume (2020-2035) & (K Units)
Figure 108. Global Pre-Implantation Genetic Diagnosis (PGD) Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global Pre-Implantation Genetic Diagnosis (PGD) Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global Pre-Implantation Genetic Diagnosis (PGD) Market Share Forecast by Type (2026-2035)
Figure 111. Global Pre-Implantation Genetic Diagnosis (PGD) Sales Forecast by Application (2026-2035)
Figure 112. Global Pre-Implantation Genetic Diagnosis (PGD) Market Share Forecast by Application (2026-2035)
Figure 1. Product Picture of Pre-Implantation Genetic Diagnosis (PGD)
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Pre-Implantation Genetic Diagnosis (PGD) Market Size (M USD), 2025-2035
Figure 5. Global Pre-Implantation Genetic Diagnosis (PGD) Market Size (M USD) (2020-2035)
Figure 6. Global Pre-Implantation Genetic Diagnosis (PGD) Sales (K Units) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Pre-Implantation Genetic Diagnosis (PGD) Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Pre-Implantation Genetic Diagnosis (PGD) Product Life Cycle
Figure 13. Pre-Implantation Genetic Diagnosis (PGD) Sales Share by Manufacturers in 2025
Figure 14. Global Pre-Implantation Genetic Diagnosis (PGD) Revenue Share by Manufacturers in 2025
Figure 15. Pre-Implantation Genetic Diagnosis (PGD) Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market Pre-Implantation Genetic Diagnosis (PGD) Average Price (USD/Unit) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by Pre-Implantation Genetic Diagnosis (PGD) Revenue in 2025
Figure 18. Industry Chain Map of Pre-Implantation Genetic Diagnosis (PGD)
Figure 19. Global Pre-Implantation Genetic Diagnosis (PGD) Market PEST Analysis
Figure 20. Global Pre-Implantation Genetic Diagnosis (PGD) Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Pre-Implantation Genetic Diagnosis (PGD) Market Share by Type
Figure 27. Sales Market Share of Pre-Implantation Genetic Diagnosis (PGD) by Type (2020-2025)
Figure 28. Sales Market Share of Pre-Implantation Genetic Diagnosis (PGD) by Type in 2025
Figure 29. Market Share of Pre-Implantation Genetic Diagnosis (PGD) by Type (2020-2025)
Figure 30. Market Share of Pre-Implantation Genetic Diagnosis (PGD) by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Pre-Implantation Genetic Diagnosis (PGD) Market Share by Application
Figure 33. Global Pre-Implantation Genetic Diagnosis (PGD) Sales Market Share by Application (2020-2025)
Figure 34. Global Pre-Implantation Genetic Diagnosis (PGD) Sales Market Share by Application in 2025
Figure 35. Global Pre-Implantation Genetic Diagnosis (PGD) Market Share by Application (2020-2025)
Figure 36. Global Pre-Implantation Genetic Diagnosis (PGD) Market Share by Application in 2025
Figure 37. Global Pre-Implantation Genetic Diagnosis (PGD) Sales Growth Rate by Application (2020-2025)
Figure 38. Global Pre-Implantation Genetic Diagnosis (PGD) Sales Market Share by Region (2020-2025)
Figure 39. Global Pre-Implantation Genetic Diagnosis (PGD) Market Size by Region (2020-2025)
Figure 40. North America Pre-Implantation Genetic Diagnosis (PGD) Sales and Growth Rate (2020-2025) & (K Units)
Figure 41. North America Pre-Implantation Genetic Diagnosis (PGD) Sales and Growth Rate (2020-2025) & (K Units)
Figure 42. North America Pre-Implantation Genetic Diagnosis (PGD) Sales Market Share by Country in 2024
Figure 43. North America Pre-Implantation Genetic Diagnosis (PGD) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Pre-Implantation Genetic Diagnosis (PGD) Market Size by Country in 2024
Figure 45. U.S. Pre-Implantation Genetic Diagnosis (PGD) Sales and Growth Rate (2020-2025) & (K Units)
Figure 46. U.S. Pre-Implantation Genetic Diagnosis (PGD) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Pre-Implantation Genetic Diagnosis (PGD) Sales (K Units) and Growth Rate (2020-2025)
Figure 48. Canada Pre-Implantation Genetic Diagnosis (PGD) Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Pre-Implantation Genetic Diagnosis (PGD) Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Pre-Implantation Genetic Diagnosis (PGD) Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Pre-Implantation Genetic Diagnosis (PGD) Sales and Growth Rate (2020-2025) & (K Units)
Figure 52. Europe Pre-Implantation Genetic Diagnosis (PGD) Sales Market Share by Country in 2024
Figure 53. Europe Pre-Implantation Genetic Diagnosis (PGD) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Pre-Implantation Genetic Diagnosis (PGD) Market Size by Country in 2024
Figure 55. Germany Pre-Implantation Genetic Diagnosis (PGD) Sales and Growth Rate (2020-2025) & (K Units)
Figure 56. Germany Pre-Implantation Genetic Diagnosis (PGD) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Pre-Implantation Genetic Diagnosis (PGD) Sales and Growth Rate (2020-2025) & (K Units)
Figure 58. France Pre-Implantation Genetic Diagnosis (PGD) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Pre-Implantation Genetic Diagnosis (PGD) Sales and Growth Rate (2020-2025) & (K Units)
Figure 60. U.K. Pre-Implantation Genetic Diagnosis (PGD) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Pre-Implantation Genetic Diagnosis (PGD) Sales and Growth Rate (2020-2025) & (K Units)
Figure 62. Italy Pre-Implantation Genetic Diagnosis (PGD) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Pre-Implantation Genetic Diagnosis (PGD) Sales and Growth Rate (2020-2025) & (K Units)
Figure 64. Spain Pre-Implantation Genetic Diagnosis (PGD) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Pre-Implantation Genetic Diagnosis (PGD) Sales and Growth Rate (K Units)
Figure 66. Asia Pacific Pre-Implantation Genetic Diagnosis (PGD) Sales Market Share by Region in 2024
Figure 67. Asia Pacific Pre-Implantation Genetic Diagnosis (PGD) Market Size by Region in 2024
Figure 68. China Pre-Implantation Genetic Diagnosis (PGD) Sales and Growth Rate (2020-2025) & (K Units)
Figure 69. China Pre-Implantation Genetic Diagnosis (PGD) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Pre-Implantation Genetic Diagnosis (PGD) Sales and Growth Rate (2020-2025) & (K Units)
Figure 71. Japan Pre-Implantation Genetic Diagnosis (PGD) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Pre-Implantation Genetic Diagnosis (PGD) Sales and Growth Rate (2020-2025) & (K Units)
Figure 73. South Korea Pre-Implantation Genetic Diagnosis (PGD) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Pre-Implantation Genetic Diagnosis (PGD) Sales and Growth Rate (2020-2025) & (K Units)
Figure 75. India Pre-Implantation Genetic Diagnosis (PGD) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Pre-Implantation Genetic Diagnosis (PGD) Sales and Growth Rate (2020-2025) & (K Units)
Figure 77. Southeast Asia Pre-Implantation Genetic Diagnosis (PGD) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Pre-Implantation Genetic Diagnosis (PGD) Sales and Growth Rate (K Units)
Figure 79. South America Pre-Implantation Genetic Diagnosis (PGD) Sales Market Share by Country in 2024
Figure 80. South America Pre-Implantation Genetic Diagnosis (PGD) Market Size and Growth Rate (M USD)
Figure 81. South America Pre-Implantation Genetic Diagnosis (PGD) Market Size by Country in 2024
Figure 82. Brazil Pre-Implantation Genetic Diagnosis (PGD) Sales and Growth Rate (2020-2025) & (K Units)
Figure 83. Brazil Pre-Implantation Genetic Diagnosis (PGD) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Pre-Implantation Genetic Diagnosis (PGD) Sales and Growth Rate (2020-2025) & (K Units)
Figure 85. Argentina Pre-Implantation Genetic Diagnosis (PGD) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Pre-Implantation Genetic Diagnosis (PGD) Sales and Growth Rate (2020-2025) & (K Units)
Figure 87. Columbia Pre-Implantation Genetic Diagnosis (PGD) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Pre-Implantation Genetic Diagnosis (PGD) Sales and Growth Rate (K Units)
Figure 89. Middle East and Africa Pre-Implantation Genetic Diagnosis (PGD) Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Pre-Implantation Genetic Diagnosis (PGD) Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Pre-Implantation Genetic Diagnosis (PGD) Market Size by Region in 2024
Figure 92. Saudi Arabia Pre-Implantation Genetic Diagnosis (PGD) Sales and Growth Rate (2020-2025) & (K Units)
Figure 93. Saudi Arabia Pre-Implantation Genetic Diagnosis (PGD) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Pre-Implantation Genetic Diagnosis (PGD) Sales and Growth Rate (2020-2025) & (K Units)
Figure 95. UAE Pre-Implantation Genetic Diagnosis (PGD) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Pre-Implantation Genetic Diagnosis (PGD) Sales and Growth Rate (2020-2025) & (K Units)
Figure 97. Egypt Pre-Implantation Genetic Diagnosis (PGD) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Pre-Implantation Genetic Diagnosis (PGD) Sales and Growth Rate (2020-2025) & (K Units)
Figure 99. Nigeria Pre-Implantation Genetic Diagnosis (PGD) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Pre-Implantation Genetic Diagnosis (PGD) Sales and Growth Rate (2020-2025) & (K Units)
Figure 101. South Africa Pre-Implantation Genetic Diagnosis (PGD) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Pre-Implantation Genetic Diagnosis (PGD) Production Market Share by Region (2020-2025)
Figure 103. North America Pre-Implantation Genetic Diagnosis (PGD) Production (K Units) Growth Rate (2020-2025)
Figure 104. Europe Pre-Implantation Genetic Diagnosis (PGD) Production (K Units) Growth Rate (2020-2025)
Figure 105. Japan Pre-Implantation Genetic Diagnosis (PGD) Production (K Units) Growth Rate (2020-2025)
Figure 106. China Pre-Implantation Genetic Diagnosis (PGD) Production (K Units) Growth Rate (2020-2025)
Figure 107. Global Pre-Implantation Genetic Diagnosis (PGD) Sales Forecast by Volume (2020-2035) & (K Units)
Figure 108. Global Pre-Implantation Genetic Diagnosis (PGD) Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global Pre-Implantation Genetic Diagnosis (PGD) Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global Pre-Implantation Genetic Diagnosis (PGD) Market Share Forecast by Type (2026-2035)
Figure 111. Global Pre-Implantation Genetic Diagnosis (PGD) Sales Forecast by Application (2026-2035)
Figure 112. Global Pre-Implantation Genetic Diagnosis (PGD) Market Share Forecast by Application (2026-2035)
